[Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations]. 1981

C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D009136 Muscular Dystrophies A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS. Muscular Dystrophy,Myodystrophica,Myodystrophy,Dystrophies, Muscular,Dystrophy, Muscular,Myodystrophicas,Myodystrophies
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D011770 Pyruvate Kinase ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40. L-Type Pyruvate Kinase,M-Type Pyruvate Kinase,M1-Type Pyruvate Kinase,M2-Type Pyruvate Kinase,Pyruvate Kinase L,R-Type Pyruvate Kinase,L Type Pyruvate Kinase,M Type Pyruvate Kinase,M1 Type Pyruvate Kinase,M2 Type Pyruvate Kinase,Pyruvate Kinase, L-Type,Pyruvate Kinase, M-Type,Pyruvate Kinase, M1-Type,Pyruvate Kinase, M2-Type,Pyruvate Kinase, R-Type,R Type Pyruvate Kinase
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females

Related Publications

C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
August 1977, Clinica chimica acta; international journal of clinical chemistry,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
May 1977, Journal of the neurological sciences,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
November 1971, The Journal of laboratory and clinical medicine,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
December 1983, Italian journal of neurological sciences,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
April 1971, Klinische Wochenschrift,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
October 1966, Life sciences,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
May 1983, American journal of medical genetics,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
October 1969, Klinische Wochenschrift,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
January 1986, European neurology,
C Calandi, and C Adami Lami, and T Guidotti, and R Nistri, and S Papuzza, and P Tozzi, and G Poggi
August 1986, Minerva pediatrica,
Copied contents to your clipboard!